Abstract
Background: The instability of aldehydes in biological matrices is associated with their reactions with thiol and amino moieties in proteins. This chemical reaction is reversible by nature and highly pH dependent. Method: A novel approach that includes protein precipitation with an acidic solution of acetonitrile/water/formic acid (85/14/1; v/v/v) was developed to efficiently recover Aldehyde-1 from plasma by shifting the equilibrium toward the formation of the free form. Results: This enabled the support of two GLP studies where Aldehyde-1 was administered to mice. The recovery of Aldehyde-1 from plasma exceeded 88% at three concentration levels. Plasma stability was confirmed at ambient conditions for 24 h and in the freezer for at least 43 (-20°C) and 64 (-70°C) days.
Papers of special note have been highlighted as: • of interest
References
- 1. . Glossary of class names of organic compounds and reactive intermediates based on structure (IUPAC Recommendations 1995). Pure Appl. Chem. 67(819), 1307–1375 (1995).
- 2. Encyclopædia Britannica. Aldehydes. www.britannica.com/science/aldehyde
- 3. . Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. Crit. Rev. Toxicol. 35(7), 609–662 (2005). • A comprehensive review on aldehydes from multiple sources, their reactivity towards biomolecules and their contribution to human diseases.
- 4. . Bioanalytical and mass spectrometric methods for aldehyde profiling in biological fluids. Toxics 7(2), 32 (2019).
- 5. . Biogenic aldehydes as therapeutic targets for cardiovascular disease. Curr. Opin. Pharmacol. 33, 56–63 (2017).
- 6. . Aldehyde toxicity and metabolism: the role of aldehyde dehydrogenase in detoxification, drug resistance and carcinogenesis. Drug Metab. Rev. 51(1), 42–64 (2019). • Excellent review on the enzymes responsible for detoxification of aldehydes in human body.
- 7. . Drug metabolizing enzymes and biotransformation reaction. In: ADME-Enabling Technologies in Drug Design and Development (1st Edition).. Zhang DSurapaneni S (Eds). John Wiley & Sons, Inc., NJ, USA, 545–565 (2012).
- 8. Reactive aldehyde metabolites from the anti-HIV drug abacavir: amino acid adducts as possible factors in abacavir toxicity. Chem. Res. Toxicol. 24(12), 2129–2141 (2011).
- 9. . Identification of a novel CYP2C19-mediated metabolic pathway of S-citalopram in vitro. Drug Metab. Dispos. 37(12), 2340–2348 (2009).
- 10. . Metabolism of pyridalyl in rats. Drug Metab. Dispos. 37, 2284–2289 (2009).
- 11. . Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies. Blood Rev. 6(3), 163–173 (1992). • Describes the use of alkylating agents in clinical practice. Good discussion on mode of action and mechanism of drug resistance of some alkylating agents.
- 12. . Induction of DNA strand breaks by reduced nitroimidazoles: implications for DNA base damage. Biochem. Pharmacol. 35(22), 3923–3928 (1986).
- 13. . The metabolic activation of abacavir by human liver cytosol and expressed human alcohol dehydrogenase isozymes. Chem. Biol. Interact. 142, 135–154 (2002).
- 14. Reactivity of atropaldehyde, a felbamate metabolite in human liver tissue in vitro. Chem. Biol. Interact. 142, 119–134 (2002).
- 15. . Exploring the binding behavior of beer staling aldehydes in model systems. J. Am. Soc. Brew. Chem. 73(1), 100–108 (2015).
- 16. . How formaldehyde reacts with amino acids. Commun. Chem. 2, 126 (2019).
- 17. . Comparison of the reactivity of trapping reagents toward electrophiles: cysteine derivatives can be bifunctional trapping reagents. Chem. Res. Toxicol. 28, 1546–1555 (2015). • Discusses the advantages of using cysteine and homocysteine as trapping reagents to evaluate the potential formations of aldehydes from drug candidates at early drug discovery.
- 18. . LC–MS/MS reveals the formation of aldehydes and iminium reactive intermediates in foretinib metabolism: phase I metabolic profiling. RSC Adv. 7, 36279–36287 (2017).
- 19. . Detection and characterization of olmutinib reactive metabolites by LC–MS/MS: elucidation of bioactivation pathways. J. Sep. Sci. 43, 708–718 (2020).
- 20. . Reactive intermediates and bioactivation pathways characterization of avitinib by LC–MS/MS: in vitro metabolic investigation. J. Pharm. Biomed. Anal. 164, 659–667 (2019).
- 21. . Characterization of reactive intermediates formation in dacomitinib metabolism and bioactivation pathways elucidation by LC–MS/MS: in vitro phase I metabolic investigation. RSC Adv. 8, 38733–38744 (2018).
- 22. . Reactive intermediates in copanlisib metabolism identified by LC–MS/MS: phase I metabolic profiling. RSC Adv. 9, 6409–6418 (2019).
- 23. . Application of DNPH derivatization with LC/MS to the identification of polar carbonyl disinfection by-products in drinking water. Ozone Sci. Eng. 22, 653–675 (2000).
- 24. . Derivatization reagents in liquid chromatography/electrospray ionization tandem mass spectrometry. Biomed. Chromatogr. 25, 1–10 (2011). • Overview describing the utility of derivatization reagents to improve the chromatographic separation and ionization efficiency of low-molecular-weight molecules.
- 25. . Synthesis of 4-[2-(N,N-dimethylamino)ethylaminosulfonyl]-7-N-methylhydrazino-2,1,3-benzoxadiazole (DAABD-MHz) as a derivatization reagent for aldehydes in liquid chromatography/electrospray ionization–tandem mass spectrometry. Biomed. Chromatogr. 22, 115–118 (2008).
- 26. . A modified Girard derivatizing reagent for universal profiling and trace analysis of aldehydes and ketones by electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 21, 2926–2932 (2007).
- 27. Use of S-pentafluorophenyl tris(2,4,6-trimethoxyphenyl)phosphonium acetate bromide and (4-hydrazino-4-oxobutyl) [tris(2,4,6-trimethoxyphenyl)phosphonium bromide for the derivatization of alcohols, aldehydes and ketones for detection by liquid chromatography/electrospray mass spectrometry. Rapid Commun. Mass Spectrom. 17, 484–497 (2003).
- 28. . A liquid chromatography–mass spectrometry method based on post column derivatization for automated analysis of urinary hexanal and heptanal. J. Chromatogr. A 1493, 57–63 (2017).
- 29. . O-methylhydroxylamine as a new trapping reagent for quantitative studies of 4-hydroxycyclophosphamide and aldophosphamide. J. Pharm. Sci. 71(4), 443–446 (1982).
- 30. . Liquid chromatography–tandem mass spectrometry for the determination of low-molecular mass aldehydes in human urine. J. Chromatogr. B 878, 653–658 (2010).
- 31. New method for HPLC separation and fluorescence detection of malonaldehyde in normal human plasma. J. Chromatogr. B 832, 103–108 (2006).
- 32. . Determination of malondialdehyde in human plasma by fully automated solid phase analytical derivatization. J. Chromatogr. B 877, 1292–1298 (2009).
- 33. . Saliva-available carbonyl compounds in some chewing tobaccos. J. Agric. Food Chem. 42, 2225–2230 (1994).
- 34. Nucleophilic addition of water – hydration. https://chem.libretexts.org/@go/page/36385